How to Fix High Hemoglobin: Causes & Treatments

Fixing high hemoglobin starts with finding out why it is high, because the treatment depends entirely on the cause. For some people the fix is as straightforward as using a CPAP machine at night or quitting smoking; for others it requires regular blood removal, medication, or adjusting a testosterone prescription. A hemoglobin level that stays elevated is not just a lab curiosity. Large studies of blood donors have linked high hemoglobin to roughly triple the risk of heart attack compared to people in a normal range, so identifying and addressing the cause matters for long-term health.

Why Elevated Hemoglobin Is a Problem

Hemoglobin is the oxygen-carrying protein packed inside red blood cells. When there is too much of it, blood becomes thicker and flows less smoothly through small vessels. Research in high-altitude populations with excessive red blood cell production found that blood viscosity was about 48 percent higher and hemoglobin roughly 23 percent higher in affected individuals compared to those without the condition, and a key measure of blood-vessel function was significantly impaired as a result.1PubMed. Global REACH 2018: High Blood Viscosity and Hemoglobin Concentration Contribute to Reduced Flow-Mediated Dilation in High-Altitude Excessive Erythrocytosis That vascular impairment was acutely reversible when the blood was thinned by removing some of it, which confirmed the high hemoglobin itself was doing the damage.

A large study of over 1.5 million blood donors in Sweden and Denmark tracked cardiovascular events for years. Men with hemoglobin at or above 17.5 g/dL had about 3.5 times the risk of heart attack and over twice the risk of ischemic stroke compared to a middle reference group. Women at or above 16.0 g/dL showed a similarly elevated pattern.2PubMed Central. Hemoglobin Concentration and Risk of Arterial and Venous Thrombosis in 1.5 Million Swedish and Danish Blood Donors Separately, a Norwegian population study found that each 5 percent increase in hematocrit (the percentage of blood volume occupied by red cells) raised the risk of venous blood clots by about a third.3Haematologica. Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study And among people who had already suffered a stroke, high hemoglobin was associated with nearly three times the risk of dying afterward and a higher chance of having another stroke.4PubMed Central. Hemoglobin Concentration and Clinical Outcomes After Acute Ischemic Stroke or Transient Ischemic Attack

The takeaway is that persistently high hemoglobin is not benign. The risks include heart attack, stroke, and blood clots in both arteries and veins. Treatment is aimed at bringing hemoglobin back into a normal range and, ideally, eliminating whatever pushed it up in the first place.

The Most Common Causes

Doctors broadly split high hemoglobin into two buckets. In “primary” erythrocytosis, the bone marrow overproduces red blood cells on its own because of a genetic mutation. In “secondary” erythrocytosis, something outside the marrow is sending signals to ramp up production, usually because the body senses it is not getting enough oxygen. There is also a third, sometimes overlooked category: “relative” erythrocytosis, where hemoglobin appears high only because plasma volume is low (think chronic dehydration or heavy diuretic use), not because red cell mass is actually increased.5Cardiology in Review. Gaisbock Syndrome: A Review of Contemporary Studies, Pathogenesis, Complications, and Possible Treatment

Secondary causes account for the majority of elevated hemoglobin in everyday clinical practice. The most frequent culprits include:

When the Bone Marrow Itself Is the Problem

Polycythemia vera (PV) is the textbook primary cause of high hemoglobin. It is a slow-growing blood cancer in which a mutation in the JAK2 gene causes the marrow to churn out red cells without the normal checks. More than 95 percent of PV patients carry this mutation, which makes it a useful diagnostic marker.10JAMA. Diagnosis and Treatment of Polycythemia Vera: A Review The diagnosis is considered when hemoglobin exceeds roughly 16.5 g/dL in men or 16.0 g/dL in women along with a positive JAK2 test.11PubMed. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management

PV is far less common than secondary causes, but it is important to catch because it carries its own set of risks, including blood clots, progression to scarring of the bone marrow, and, in a small fraction, transformation into acute leukemia. Treatment is covered in a later section.

There are also rare inherited forms of erythrocytosis unrelated to PV. Mutations in the oxygen-sensing pathway or in the hemoglobin genes themselves can lock the body into overproducing red cells from birth.12PubMed Central. Genetic Background of Congenital Erythrocytosis These are uncommon, but they are worth considering in young people who have had high hemoglobin for as long as anyone can remember, especially if there is a family history.

How the Cause Is Identified

Because the treatment hinges on the underlying reason, a proper workup matters. The standard approach starts with confirming that hemoglobin is genuinely elevated on more than one blood draw (a single high reading can be a fluke from dehydration). After that, two key tests steer the investigation: a JAK2 mutation test and an EPO level.13PubMed Central. A Practical Approach to Polycythemia in the Outpatient Setting and Its Importance

A positive JAK2 result points strongly toward polycythemia vera and warrants referral to a hematologist. A low EPO level in someone who is JAK2-negative still raises suspicion for a marrow-driven problem and typically prompts further genetic testing. A high or normal EPO level, on the other hand, redirects the investigation toward secondary causes: lung function tests, overnight oxygen monitoring for sleep apnea, a medication review (especially testosterone, androgens, or certain diabetes drugs), and abdominal imaging to look for kidney or liver masses.14CMAJ. Investigation and management of erythrocytosis A thorough medication review is especially relevant given how many patients are now on testosterone replacement or similar hormonal therapies.15Leukemia. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views

Treating Secondary Causes Directly

If the elevated hemoglobin is being driven by an identifiable trigger, the most effective fix is usually to remove or treat that trigger. For many people, this alone brings hemoglobin back to normal.

Sleep Apnea and CPAP

For patients whose hemoglobin is elevated because of obstructive sleep apnea, continuous positive airway pressure (CPAP) is the frontline treatment. A meta-analysis pooling data from ten trials found that CPAP reduced hemoglobin by an average of about 3.8 g/L and hematocrit by roughly 1.1 percentage points.16PubMed. Prevalence of elevated hemoglobin and hematocrit levels in patients with obstructive sleep apnea and the impact of treatment with continuous positive airway pressure: a meta-analysis That sounds modest, but in patients with frank polycythemia (hemoglobin above 17 g/dL or so), CPAP corrected levels to normal in the majority of cases. In one study of polycythemic sleep apnea patients, average hemoglobin dropped from about 17.4 g/dL to normal levels with CPAP use.17Blood. Polycythemia Is Rarely Caused By Obstructive Sleep Apnea A separate study found a drop from about 18.0 to 16.9 g/dL after CPAP with a statistically meaningful difference.18European Respiratory Journal. Erythrocytosis and hypopnea syndrome sleep apnea. Effect of CPAP

One caveat: in some patients hemoglobin initially came down with CPAP but crept back up over a year or more despite continued use. This suggests that if hemoglobin rises again in someone on CPAP, there may be a second cause that needs investigating.17Blood. Polycythemia Is Rarely Caused By Obstructive Sleep Apnea

Smoking Cessation

Quitting smoking removes the carbon monoxide load on hemoglobin and eliminates the chronic oxygen deficit that drives extra red cell production.19Population Medicine. Adverse effects of cigarette smoking on exhaled breath carbon monoxide, blood carboxyhemoglobin, and hematological parameters amongst Sri Lankan adult tobacco smokers Hemoglobin typically drifts downward over weeks to months after quitting. No special hematologic intervention is needed beyond the cessation itself, though if levels remain stubbornly high, a sleep study or other workup is warranted.

Adjusting Testosterone Therapy

For patients on testosterone replacement who develop erythrocytosis, the usual first step is a dose reduction. A randomized pilot study found that lowering the testosterone dose kept hematocrit levels stable and within acceptable limits while maintaining therapeutic testosterone levels, even though it was less effective at bringing hematocrit down than stopping testosterone altogether.20The Journal of Sexual Medicine. Effect of 100 mg of testosterone cypionate in trans men with erythrocytosis: a randomized controlled pilot study Switching from injectable testosterone (which produces peaks and troughs) to a topical formulation that delivers a steadier blood level is another commonly tried strategy. In more severe cases, temporary suspension of testosterone may be necessary.

Therapeutic Phlebotomy

Phlebotomy, meaning the controlled removal of a unit of blood, is the fastest way to bring hemoglobin and hematocrit down. It is the cornerstone treatment for polycythemia vera and is used as a bridge or supplement in secondary erythrocytosis when the underlying cause cannot be fixed quickly. The goal in PV is typically to keep hematocrit below 45 percent.

A recent comparative study found that each additional phlebotomy session lowered hemoglobin progressively, and that a single session of a more intensive procedure called erythrocytapheresis (which selectively removes red cells while returning plasma) achieved a hemoglobin reduction comparable to two or three standard phlebotomies.21PubMed. Evaluation of the efficacy of erythrocytapheresis and phlebotomy in the treatment of polycythemia Erythrocytapheresis is less widely available and more expensive, but it can be useful when frequent phlebotomy visits are impractical.

One area of genuine debate is whether phlebotomy makes sense for testosterone-induced erythrocytosis specifically. A review of the evidence found that there is currently no strong data supporting the effectiveness or safety of phlebotomy for lowering hematocrit in patients whose high levels are driven by testosterone therapy.22Endocrine Connections. Testosterone therapy-induced erythrocytosis: can phlebotomy be justified? Repeated phlebotomies can deplete iron stores, which may paradoxically worsen symptoms like fatigue even if hematocrit drops. For this group, dose adjustment tends to be a more sustainable solution.

Medications for Polycythemia Vera

Phlebotomy alone is sufficient for some PV patients, particularly younger patients without a history of blood clots. But when the disease is higher-risk (roughly age 65 or older, or a prior thrombotic event), medications that tamp down marrow activity are added.23PubMed Central. Advances in the Treatment of Polycythemia Vera: Trends in Disease Management

Hydroxyurea has been the standard first-line cytoreductive drug for decades. It works by slowing down cell division in the marrow, bringing red cell counts, white cell counts, and platelet counts closer to normal. The downside is that some patients do not tolerate it well, and there has been longstanding concern about a small leukemia-promoting potential with very long-term use.24PubMed. Recommendations for the diagnosis and treatment of patients with polycythaemia vera

Pegylated interferon (specifically ropeginterferon alfa-2b) has emerged as a major alternative. It has shown efficacy at least comparable to hydroxyurea and may actually reduce the burden of the JAK2 mutation over time, something hydroxyurea does not reliably do. Its pegylated form is given less frequently than older interferon preparations and produces fewer flu-like side effects, making it more tolerable for long-term use.24PubMed. Recommendations for the diagnosis and treatment of patients with polycythaemia vera Ruxolitinib, a drug that directly blocks the overactive JAK signaling pathway, is approved for patients who cannot tolerate or do not respond to hydroxyurea.23PubMed Central. Advances in the Treatment of Polycythemia Vera: Trends in Disease Management

When the Fix Is Hydration, Not Hematology

Relative erythrocytosis catches people off guard because the red blood cell count is not actually increased; the liquid portion of blood (plasma) is decreased, making hemoglobin look artificially high. Chronic dehydration, heavy alcohol use, diuretic medications, and the stress-related condition sometimes called Gaisböck syndrome can all produce this pattern.5Cardiology in Review. Gaisbock Syndrome: A Review of Contemporary Studies, Pathogenesis, Complications, and Possible Treatment The fix in these cases may be as simple as improving fluid intake or adjusting a blood-pressure medication. Confirming relative versus absolute erythrocytosis sometimes requires a nuclear medicine test that directly measures red cell mass, though that test is not available everywhere.14CMAJ. Investigation and management of erythrocytosis

Iron Supplementation and Hemoglobin

People sometimes worry that taking iron supplements or eating an iron-rich diet could push hemoglobin dangerously high. In practice, this is extremely unlikely if your bone marrow and EPO signaling are normal. The body has strong feedback mechanisms that slow iron absorption when stores are adequate. Research on blood donors given oral iron found that the effect on red blood cell recovery was minimal when baseline iron stores were already replete, but substantial when stores were depleted.25PubMed Central. The benefits of iron supplementation following blood donation vary with baseline iron status In other words, iron supplements mainly help when you are low; they do not keep ratcheting hemoglobin upward in a healthy person. The one group that does need to be careful is PV patients undergoing phlebotomy, who sometimes become iron-deficient by design. Their doctors may deliberately withhold iron to help keep red cell production in check.

High Hemoglobin in Newborns

Neonatal polycythemia is a distinct clinical situation with its own set of causes. It is defined as a venous hematocrit of 65 percent or higher, which is much higher than normal adult ranges. Babies born post-term, those who are small for gestational age, infants of mothers with diabetes, and recipients in twin-to-twin transfusion syndrome are all at increased risk.26NeoReviews. Polycythemia in the Newborn The concern is that the thick blood impairs flow through tiny vessels, potentially affecting the brain, lungs, and gut. In symptomatic newborns, a partial exchange transfusion (swapping some of the baby’s thick blood for saline or albumin) is the standard treatment.27PubMed Central. Neonatal polycythaemia This is quite different from adult management, and the decision is usually made by neonatologists based on symptoms rather than a fixed hematocrit cutoff.

High Altitude and Hemoglobin

Living at high altitude is one of the most predictable drivers of elevated hemoglobin. Thin air means less oxygen per breath, and the body compensates by making more red cells. For lowlanders who move to altitude, hemoglobin rises over weeks and usually plateaus at a new, higher normal. In some individuals, especially those of Andean descent living above about 3,500 meters, the response overshoots into what is called excessive erythrocytosis, with hemoglobin levels above 21 g/dL and symptoms including headache, dizziness, and impaired blood vessel function.1PubMed. Global REACH 2018: High Blood Viscosity and Hemoglobin Concentration Contribute to Reduced Flow-Mediated Dilation in High-Altitude Excessive Erythrocytosis

Interestingly, not all highland populations respond the same way. Tibetans, who have lived at altitude for thousands of years longer than Andean populations, have adapted differently. Their hemoglobin levels are lower than those of both lowlanders and Andeans at the same altitude, and they maintain higher oxygen saturation at rest and during exercise.28PubMed. High altitude adaptation in Tibetans Research has confirmed that this is not due to changes in hemoglobin’s oxygen-binding properties but rather to other genetic adaptations in the oxygen-sensing pathway.29PubMed Central. High altitude genetic adaptation in Tibetans: no role of increased hemoglobin-oxygen affinity The Tibetan pattern suggests that cranking up hemoglobin is not the only way, or even the best way, for the body to cope with thin air. For people living at high altitude who develop excessive erythrocytosis, the most reliable fix is relocation to lower elevation, though periodic phlebotomy and supplemental oxygen are sometimes used when moving is not practical.